Market Research Logo

Pharmaceuticals in Mexico

Pharmaceuticals in Mexico

Summary

Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Mexico pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The Mexican pharmaceuticals market had total revenues of $20.3bn in 2017, representing a compound annual growth rate (CAGR) of 5.8% between 2013 and 2017.
  • In line with many developing nations, Mexico has been experiencing an epidemiological transition from communicable diseases to chronic degenerative diseases. It is these factors which are generating growth.
  • A growing middle class and better access to health care services are greatly increasing consumer demand for pharmaceutical products in Mexico.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Mexico
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Mexico
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts
Reasons to buy
  • What was the size of the Mexico pharmaceuticals market by value in 2017?
  • What will be the size of the Mexico pharmaceuticals market in 2022?
  • What factors are affecting the strength of competition in the Mexico pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Mexico's pharmaceuticals market?


Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: Mexico pharmaceuticals market value: $ billion, 2013-17
Table 2: Mexico pharmaceuticals market geography segmentation: $ billion, 2017
Table 3: Mexico pharmaceuticals market share: % share, by value, 2017
Table 4: Mexico pharmaceuticals market value forecast: $ billion, 2017-22
Table 5: Bayer AG: key facts
Table 6: Bayer AG: key financials ($)
Table 7: Bayer AG: key financials (€)
Table 8: Bayer AG: key financial ratios
Table 9: Merck & Co., Inc.: key facts
Table 10: Merck & Co., Inc.: key financials ($)
Table 11: Merck & Co., Inc.: key financial ratios
Table 12: Novartis AG: key facts
Table 13: Novartis AG: key financials ($)
Table 14: Novartis AG: key financial ratios
Table 15: Pfizer Inc.: key facts
Table 16: Pfizer Inc.: key financials ($)
Table 17: Pfizer Inc.: key financial ratios
Table 18: Mexico size of population (million), 2013-17
Table 19: Mexico gdp (constant 2005 prices, $ billion), 2013-17
Table 20: Mexico gdp (current prices, $ billion), 2013-17
Table 21: Mexico inflation, 2013-17
Table 22: Mexico consumer price index (absolute), 2013-17
Table 23: Mexico exchange rate, 2013-17
List of Figures
Figure 1: Mexico pharmaceuticals market value: $ billion, 2013-17
Figure 2: Mexico pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: Mexico pharmaceuticals market share: % share, by value, 2017
Figure 4: Mexico pharmaceuticals market value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the pharmaceuticals market in Mexico, 2017
Figure 6: Drivers of buyer power in the pharmaceuticals market in Mexico, 2017
Figure 7: Drivers of supplier power in the pharmaceuticals market in Mexico, 2017
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2017
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2017
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2017
Figure 11: Bayer AG: revenues & profitability
Figure 12: Bayer AG: assets & liabilities
Figure 13: Merck & Co., Inc.: revenues & profitability
Figure 14: Merck & Co., Inc.: assets & liabilities
Figure 15: Novartis AG: revenues & profitability
Figure 16: Novartis AG: assets & liabilities
Figure 17: Pfizer Inc.: revenues & profitability
Figure 18: Pfizer Inc.: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report